Association of Preoperative Coronary Calcium Score and Postoperative Atrial Arrythmia in Patients Undergoing Robot-assisted Esophagectomy: Prospective Observational Study
Launched by YONSEI UNIVERSITY · Jun 25, 2025
Trial Information
Current as of July 27, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying whether the amount of calcium in the heart’s arteries, measured before surgery, is linked to the chance of developing an irregular heartbeat called atrial fibrillation after a robot-assisted surgery to remove part of the esophagus (the tube that carries food from the mouth to the stomach). Doctors want to understand if the calcium score can help predict who might experience this heart issue after the procedure.
Patients who are 20 years or older and scheduled for this type of robotic esophagus surgery may be able to join the study, as long as they have had a special heart scan before surgery that measures calcium in their heart arteries. People who have had emergency surgery, cannot understand or sign consent forms, have memory or thinking problems, are pregnant or breastfeeding, or have a history of irregular heartbeat before surgery will not be eligible. If you join, your medical team will review your pre-surgery heart scan and monitor your heart rhythm after surgery to see if any irregular heartbeat develops. This study is not yet enrolling participants but aims to help doctors better predict and manage heart risks in patients undergoing this surgery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients aged 20 years or older undergoing robotic esophagectomy
- • Patients who underwent preoperative coronary computed tomography (CT) with a valid coronary artery calcium score
- Exclusion Criteria:
- • emergency surgery
- • patients who cannot read consent forms(e.g., illiterate, foreigner, etc.)
- • patients with cognitive dysfunction
- • pregnant, lactating women
- • history of atrial fibrillation prior to surgery
About Yonsei University
Yonsei University, a prestigious institution located in South Korea, is renowned for its commitment to advancing medical research and education. As a clinical trial sponsor, Yonsei University leverages its extensive expertise and innovative approaches in various fields of medicine to conduct rigorous clinical trials aimed at improving patient outcomes and advancing healthcare solutions. The university's robust infrastructure, multidisciplinary collaboration, and adherence to ethical standards ensure the integrity and reliability of its research initiatives, making it a key player in the global clinical research landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Seoul, , Korea, Republic Of
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported